BELLUS Health Convenes KOL Meeting to Discuss the State of Chronic Cough Treatment
– Professor Jacky Smith from the University of Manchester to lead live webcast – LAVAL, Quebec–(BUSINESS WIRE)–BELLUS Health Inc. (TSX:…
Pharmaceuticals, Biotechnology and Life Sciences
– Professor Jacky Smith from the University of Manchester to lead live webcast – LAVAL, Quebec–(BUSINESS WIRE)–BELLUS Health Inc. (TSX:…
– 87% reduction in average number of Gb3 inclusions in first kidney biopsy taken one year post-treatment, the primary efficacy…
EMERYVILLE, Calif.–(BUSINESS WIRE)–#Avenova—NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care…
DUBLIN–(BUSINESS WIRE)–The “Asthma and COPD Drugs Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to…
– Data demonstrate statistically significant biomarker activity at well-tolerated dose in PKU patients – – Plan to initiate bridging study…
First and only FDA-approved sprinkle formulation of rosuvastatin Extended-release-coated granules designed to facilitate once-daily administration especially for the 30-35% of…
– Gilead to Make $3.95 Billion Upfront Payment and $1.1 Billion Equity Investment – – Gilead Gains Access to Galapagos’…
TAMPA, Fla.–(BUSINESS WIRE)–#AAIC2019–Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that its senior management team led by Stephan Jackman,…
BOSTON–(BUSINESS WIRE)–Flex Pharma, Inc. (Nasdaq: FLKS) today announced that its stockholders approved all proposals relating to its planned merger with…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Reissuing release dated June 24th, 2019 to correct for searching purposes. The corrected release reads: MAGENTA THERAPEUTICS APPOINTS…